Risultati per: Raccomandazioni sullo screening del diabete per gli adulti

Fino a -25% peso per pazienti con altri fattori rischio

In Reply Our study compared the end points of cancer-specific mortality and late-stage cancer in randomized clinical trials of cancer screening. Drs Kim and Gibbs write that the relationship between these could be affected by changes in cancer staging and treatment. We agree that this is true not only for our comparison of end points, but for cancer screening in general. For example, a screening test that is effective at reducing cancer mortality could become ineffective if new treatments decrease differences in survival between stages. For the cancer types in our study, Surveillance, Epidemiology, and End Results data generally show survival improvements over time across all stages.

To the Editor A recent study offered valuable insights into the management and prognosis of advanced cancer. Nevertheless, we have several concerns about this article.

To the Editor A recent study provided a robust analysis of the association between the reduction in stage III to IV cancer diagnoses and overall survival gains in historical cancer screening trials, and the accompanying Editorial added an important epidemiological perspective. However, the relationship between cancer stage at diagnosis and survival is not static. Data from the studies examined, many of which were initiated 30 to 40 years ago, are of questionable relevance in the modern era.

L’Iniziativa promossa da Lilt (Lega italiana per la lotta contro i tumori) mette a disposizione un numero verde per effettuare le visite negli ambulatori aderenti

A 14-day monitor detected more atrial fibrillation but did not affect hospitalization rates for stroke or hemorrhage.

Fino a oggi era fissata a 50 anni. Si parte nel 2025

Annals of Internal Medicine, Ahead of Print.

Annals of Internal Medicine, Ahead of Print.

In 2009, the first state dense breast legislation was passed in Connecticut, requiring that women who undergo mammography receive written notification of breast density. This advocacy-driven policy was intended to raise women’s awareness that dense breasts are a risk factor for breast cancer and can also obscure breast cancer on mammography. Since then, 37 states and the District of Colombia have followed with their own reporting laws, and beginning in September 2024, the US Food and Drug Administration will require breast density notification to be included in mammography reports for all patients and their referring clinicians.

This model-based comparative effectiveness analysis examines the long-term benefits and harms of digital breast tomosynthesis and supplemental breast magnetic resonance imaging screening by breast density using data on screening performance from the Breast Cancer Surveillance Consortium.

Use of MRI led to fewer biopsies and fewer diagnoses of clinically insignificant cancer.

In a large observational study, women with false-positive results were less likely to return for future screening.

In una donna di 25 anni, ora produce insulina autonomamente